Skip to main content

26 September 2007

Smiths Group, the global technology company, today announces contracts won by Smiths Medical with a total value of over US$45 million.

The contracts have been won in the last two months by Smiths Medical’s Critical Care business, which provides safety needles and catheters, temperature management, airway and anaesthesia products to the US and international markets.

The contracts include:

  • A renewal of a contract with a major Group Purchasing Organisation (GPO) for IV catheters for the US hospital market, worth $30m
  • A further contract with the same GPO for hypodermic needles worth $5m
  • Additional new and secured contracts with GPO customers covering Arterial Blood Gas sampling kits, circuits and masks (anaesthesia) and hyperinflation (resuscitation) worth almost $11m

 

The contracts have a duration of either two or three years.

Srini Seshadri, Group Managing Director for Smiths Medical, said: “We have had an excellent start to the year in our Critical Care business, and continue to win new agreements while securing relationships with the largest customers in the market, which is a testament to the quality of our product ranges, and the people who sell them.”

ENDS

General media enquiries

Contact our global media and communications team at:

Tom Steiner

Tom Steiner

Head of External Communications

+44 (0) 20 7004 1600

Email Arrow right icon
Charlotte Bulmer

Charlotte Bulmer

Corporate Communications Executive

+44 (0) 20 7004 1600

Email Arrow right icon

Please note – the press team can only answer enquiries from accredited members of the press.

Related articles

Earth View

Response to shareholder letter

Find out more Call to action arrow icon
Japan Airport

Smiths Detection expands partnership with Fukuoka International Airport

Smiths Detection, part of Smiths Group, provides 3D X-ray technology to help speed passengers speed through security at Fukuoka International Airport.

Find out more Call to action arrow icon
Cityscape

Appointment of Chief Financial Officer and upgraded FY2025 guidance

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon